pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
  1. pharmadog
  2. ›drugs
  3. ›CELECOXIB
drug · small molecule
save

CELECOXIB

Phase 3updated 3mo ago
by MedinCell SA🔗 ChEMBL
Phase 3
community read0 votes

🐶 often sniffed alongside

top 8
  • tagApproval34 co-mentions · 17 sources
  • drugCelebrex25 co-mentions · 19 sources
  • drugcelecoxib SR25 co-mentions · 19 sources
  • drugElyxyb25 co-mentions · 19 sources
  • tagSmall Molecule17 co-mentions · 17 sources
  • companyLupin Ltd8 co-mentions · 8 sources
  • companyAlembic Pharmaceuticals Inc6 co-mentions · 1 sources
  • drugtadalafil4 co-mentions · 2 sources

Small molecule drug with a maximum clinical stage of Approval (across all indications), with 17 approved and 80 investigational indications.

targets

Prostaglandin G/H synthase 2

all catalysts(0)

nothing on the calendar yet

Trials studying CELECOXIB

  • phase2Intensive Locoregional Chemoimmunotherapy for Recurrent Ovarian Cancer Plus Intranodal DC Vaccineswithdrawn
  • phase2Intensive Locoregional Chemoimmunotherapy, Intradermal Autologous Alpha-DC1 Vaccines, and Systemic Pembrolizumab for Advanced-Stage Ovarian Cancernot yet recruitingn=28
  • phase2Efficacy and Safety of TRD205 Tablets for Postoperative Analgesia in Unilateral Total Hip Arthroplasty (Phase IIb)recruitingn=200
  • phase3Efficacy & Safety of rAd-IFN Administered With Celecoxib & Gemcitabine in Patients With Malignant Pleural Mesotheliomacompletedn=53
  • phase1A Phase Ib Study to Evaluate the Efficacy and Safety of HRS-2129 in Patients With Knee Osteoarthritisrecruitingn=200
  • phase2Neoadjuvant Immune Checkpoint Inhibition and Novel IO Combinations in Early-stage Colon Cancerrecruitingn=353
  • phase3Total Knee Arthroplasty (TKA) Study of HTX-011 in an Multimodal Analgesic Regimen (MMA) Regimencompletedn=116
  • phase1The Seven Trial: Exploiting the Unfolded Protein Responseactive not recruitingn=6
more trials →

News(0)

no news has mentioned this drug yet

brand
CELECOXIB
trade names
Celebra, Celebrex, Celecoxib, Celecoxib component of consensi, Celecoxib component of seglentis, Elyxyb
generic
CELECOXIB
MOA
Cyclooxygenase-2 inhibitor
indication
Post-Operative Pain
phase
phase_3
Data sources
ClinicalTrials.gov · OpenTargets
last refreshed 7m ago
Found something off?
🐶 something off?

Report a data issue

Tell Bork what looks wrong — wrong sponsor, stale phase, mislinked ticker, anything. We’ll triage and fix.

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?